BGLC · ISSUER CIK 1737523
BioNexus Gene Lab Corp
Between Aug 1, 2026 and Oct 29, 2026, 5 BioNexus Gene Lab Corp insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗5 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 14, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 202617:20 | Aug 13, 2026 | BGLC | Chief Executive Officer, Director, 10% Owner | A · Grant | — | +338,709 | 338,709 | New | — | ||
| Aug 14, 202617:19 | Aug 13, 2026 | BGLC | Director | A · Grant | — | +32,258 | 32,258 | New | — | ||
| Aug 14, 202617:18 | Aug 13, 2026 | BGLC | Director | A · Grant | — | +32,258 | 32,258 | New | — | ||
| Aug 14, 202617:17 | Aug 13, 2026 | BGLC | Chief Financial Officer | A · Grant | — | +96,774 | 96,774 | New | — | ||
| Aug 14, 202617:14 | Aug 13, 2026 | BGLC | Director | A · Grant | — | +16,129 | 17,390 | +1279% | — |